Valuation: genOway

Market Cap 22.87M 26.22M 21.59M 19.61M 36.73M 2.52B 36.89M 259M 99.8M 1.28B 98.5M 96.32M 4.12B P/E 2024 *
-
P/E 2025 -
Enterprise Value 29.58M 33.93M 27.93M 25.37M 47.53M 3.26B 47.72M 335M 129M 1.66B 127M 125M 5.33B EV / Sales 2024
1.28x
EV / Sales 2025 1.11x
Free-Float
59.02%
Yield 2024 *
-
Yield 2025 -
1 day+1.64%
1 week+0.40%
1 month+1.22%
3 months+5.53%
6 months+2.90%
Current year-8.49%
1 week 2.37
Extreme 2.37
2.5
1 month 2.37
Extreme 2.37
2.53
Current year 2.18
Extreme 2.18
2.79
1 year 2.1
Extreme 2.1
3.2
3 years 2.1
Extreme 2.1
4.91
5 years 2.1
Extreme 2.1
4.91
10 years 1
Extreme 1
7.7
Manager TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - 01/03/1999
Director of Finance/CFO - 01/10/2015
Director TitleAgeSince
Director/Board Member - 01/03/1999
Chairman - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
20/1/22 Buy

Chief Executive Officer

12,500 0.1376%
17/11/21 Sell

Chief Executive Officer

5,000 0.0553%
13/11/21 Sell

Founder

1,147 0.0127%
Change 5-day change 1-year change 3-year change Capi.($)
+1.64%+0.40%-13.29%-31.87% 26.22M
+0.11%+2.71%+0.44%+26.85% 46.28B
-1.12%+1.78%+42.30%+27.55% 43.85B
-3.04%-6.29%+338.56%+515.97% 40.93B
-0.74%+1.25%+4.92%+67.98% 39.89B
-0.50%+0.67%+10.29%+41.28% 29.5B
-0.46%+4.22%+22.81%+139.44% 17.09B
-0.97%-10.17% - - 15.55B
-0.57%+8.12%+22.19%+38.68% 15.22B
-3.14%+31.91%-11.79% - 14.05B
Average -0.88%+3.43%+46.27%+103.23% 26.24B
Weighted average by Cap. -1.10%+1.87%+68.03%+130.89%

Financials

2024 2025
Net sales 27.53M 31.57M 26M 23.61M 44.23M 3.03B 44.41M 311M 120M 1.54B 119M 116M 4.96B 28.6M 32.8M 27.01M 24.52M 45.95M 3.15B 46.14M 323M 125M 1.6B 123M 120M 5.15B
Net income 1.83M 2.1M 1.73M 1.57M 2.94M 201M 2.95M 20.71M 7.99M 102M 7.89M 7.71M 330M 928K 1.06M 876K 795K 1.49M 102M 1.5M 10.49M 4.05M 51.9M 4M 3.91M 167M
Net Debt 623K 714K 588K 534K 1M 68.55M 1M 7.05M 2.72M 34.85M 2.68M 2.62M 112M 6.72M 7.7M 6.34M 5.76M 10.79M 739M 10.84M 75.99M 29.32M 376M 28.94M 28.3M 1.21B
Logo genOway
genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).
Employees
157
Date Price Change Volume
18/09/26 EUR 2.480 +1.64% 4,727
17/09/26 EUR 2.440 +2.95% 2,688
16/09/26 EUR 2.370 -0.42% 1,094
15/09/26 EUR 2.380 -2.46% 4,387
14/09/26 EUR 2.440 -1.21% 1,408
  1. Stock Market
  2. Stocks
  3. ALGEN Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!